Trial
NCT07246785
Anrikefon-based Patient-controlled Intravenous Analgesia After Laparoscopic Surgery
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Peking University First Hospital
Collaborators
—
Condition
Laparoscopic Surgery
Intervention
High-dose anrikefon
Why stopped
The study was terminated due to substantial protocol amendments involving changes in the target population and primary endpoint, rendering previously collected data incompatible with the revised study objective.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-09